Viewing Study NCT00438659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT00438659
Status: COMPLETED
Last Update Posted: 2016-08-01
First Post: 2007-02-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Sponsor: North Central Cancer Treatment Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Dermatologic Complications View
None Radiation Toxicity View
None Skin Reactions Secondary to Radiation Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dermatologic complications View
None skin reactions secondary to radiation therapy View
None radiation toxicity View
None breast cancer in situ View
None recurrent breast cancer View
None stage I breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View
None male breast cancer View
None ductal breast carcinoma in situ View
None stage IV breast cancer View